Abraham Olvera

[BMA Foundation @BMAFoundationMR]

Congratulations to the 2024 Dawkins and Strutt grant winners: Mr Alasdair Warwick and Dr @abraham_olvera1🌟 #medresearchawards @Moorfields

[Josef Huemer @JosefHuemer1]

So proud of our team! Recognising changes on OCT is step 1, making the correct call is step 2. watch this space!such a pleasure to work with the brilliant @h_a_khalid, @sktywagner, @LimoliCeleste @LaxmiDRaja @pearsekeane, @AugenarztDrBolz @LukeNic17 and others

[Ophthalmology @AAOjournal]

Multicenter study led by @JavierZarranz @hospitalclinic highlights relevance of macular neovascularization type on clinical outcomes in wet AMD and reports differences in visual acuity & lesion activity at 1 y. @RetinaSERV @Club_Esp_Macula @FRB_Research https://t.co/91h63ufMNO

[Josef Huemer @JosefHuemer1]

Our review on tele ophthalmology for retinal diseases is out: https://t.co/uZS1PO1vfJ Great work led by Jonathan Than and Peng Sim from @Moorfields, with contributions from @Swankang, Danson Muttuvelu, @danielferraz1 and Victor Koh.

[Anand Rajesh @anand_e_rajesh]

Excited to share my work reviewing the next challenges facing AI in DR screening!

[Michael F. Chiang, MD @NEIDirector]

Lack of adoption of ocular imaging standards (DICOM) is bad for research & clinical care.

@NatEyeInstitute @US_FDA @ONC_HealthIT have developed a roadmap for interoperability together. We will consider this strongly in future research grants

@AAOjournal: https://t.co/wJ2sX376RX

[Abraham Olvera @abraham_olvera1]

Kathryn Willis leads a methods paper to explore how individuals with diabetes and NHS staff perceive AI-assisted diabetic eye screening.
A crucial step towards enhancing diabetic eye care with AI.📊👁️🤖
@SGUL_PHRI
https://t.co/lgqU623zS2

[Abraham Olvera @abraham_olvera1]

🔗Further work from the group showed persistence of disparities even among individuals deemed "low-risk" for sight-threatening DR, suggesting potential exacerbation of health inequalities with extended diabetic eye screening intervals.
👁️: https://t.co/3DPSdfN0aP

[Abraham Olvera @abraham_olvera1]

👁‍🗨Our latest study offering DR transition probabilities, unveils determinants of sight-threatening DR. By recognising ethnic and age disparities, it underscores the importance of personalised risk stratification in diabetic eye screening.
🤖Learn more: https://t.co/TQcpol5DD0

[INSIGHTeyehub @INSIGHTeyehub]

Watch @sktywagner on Germany's national broadcatser @ZDF as the AI Safety Summit begins.

Highlights AI research breakthroughs for patient benefit @Moorfields @UCLeye @uhbtrust enabled by INSIGHT. With @JosefHuemer1

👇Click to watch and read the story https://t.co/Rbr8uKI7ge

[Abraham Olvera @abraham_olvera1]

Our recent study explored the impact of biennial vs annual DR screening in a diverse population. Biennial screening could delay detection of ~half of STDR cases, particularly among certain population subgroups, potentially leading to health inequalities
https://t.co/adyjRii10x

[Abraham Olvera @abraham_olvera1]

@RetinaDiscovery Dive into the novel features of "ORCA" (Outer Retinal Columnar Abnormalities).
In this exciting report, Claudia Liang Peng and colleagues characterise ORCA in the context of dense deposit disease. 👁‍🗨🐋

[Retina Discovery Group @RetinaDiscovery]

🔬 New Research Alert:
A new publication led by Claudia Liang Peng. The first report of bilateral non-vasogenic cystoid macular oedema and outer retinal columnar abnormalities (ORCA) in the context of dense deposit disease:
https://t.co/1vV2mPeNFF

[Pearse Keane @pearsekeane]

1/

🚨🚨 New paper alert 🚨🚨

Introducing RETFound, a foundation model for ophthalmology

We’re super excited about this and hope it will act as a #Cornerstone for global efforts to prevent blindness through #AI

@UCLeye @Moorfields

#OpenAccess @Nature
https://t.co/DsvKgeUH5m

[Retina Discovery Group @RetinaDiscovery]

Out now on @BMJ_Ophth 📣
Our study, led by @abraham_olvera1, analysing the prevalence of visual impairment compared to certification of visual impairment (CVI) in patients with diabetic retinopathy (DR).

https://t.co/AdzXDc8CVc

[IOVS Journal @ARVOiovs]

Adnan Tufail @adnan_tufail1 et al. @Moorfields @UWMedicine examine whether sociodemographic and ocular factors relate to optical coherence tomography–derived foveal curvature in healthy individuals.
https://t.co/VZxpeD9zWv

[Josef Huemer @JosefHuemer1]

This was fun! We used code-free deep learning to train an algorithm to detect clinical significant posterior capsule opacification (PCO). This 🇦🇹🇬🇧collaboration between @Moorfields and Hanusch Hospital has been published now https://t.co/NAewbJPejt. 🥳 1/

[Abraham Olvera @abraham_olvera1]

Now published:
Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model https://t.co/EA25VmGW0f
Well done @AlasdairWarwick, Darren Thomas. @RetinaDiscovery

[Dr Lola Solebo 💙👶🏾👁️👩🏾‍💻 @lolaeyedoc]

A wonderful piece of art created by a ⁦@GreatOrmondSt⁩ patient who was born with #cataract and had surgery as a baby - beautifully framed and ready to hang in our new #SightAndSound building #Paedsrocks

[Ophthalmology @AAOjournal]

A big data analysis study on 15,810 eyes shows improvement in functional visual acuity over the past decade in AMD patients, but the data reveals suboptimal treatment patterns over the years. @RetinaDiscovery @Moorfields https://t.co/JJQq0H81Ne